Informal Business Practices in the Russian Pharmaceutical Sector
Type
digital resource
Date Issued
2013-10-16
Author(s)
Abstract
In spite of the financial crisis and its consequences, Russia still remains a potentially attractive market, presenting some promising investment opportunities with the potential for dynamic growth in sales and profits. But foreign investors might be faced with several significant challenges while working in Russia, because informal practices-the spoken and unspoken understandings that complement or sometimes even contradict official procedures-often prevail over formal rules and laws.
Using one pharmaceutical company as an example, this contribution shows what informal practices foreign companies might expect in Russia and how they could manage them
Using one pharmaceutical company as an example, this contribution shows what informal practices foreign companies might expect in Russia and how they could manage them
Language
English
Keywords
Russia
Informal Practices
Corruption
Pharmaceutical Sector
HSG Classification
contribution to scientific community
Refereed
No
Publisher
Edmond J. Safra Center for Ethics, Harvard University
Subject(s)
Division(s)
Eprints ID
226697